Effect of pyrazole and dexamethasone administration on cytochrome P450 2E1 and 3A isoforms in rat liver and kidney: Lack of specificity of p- nitrophenol as a substrate of P450 2E1

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 3, 1998, Pages 652-657

  Zerilli, Alain ^a   Lucas, Danièle ^a   Dreano, Yvonne ^a   Picart, Daniel ^a   Berthou, François ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

Kidney; Liver; p Nitrophenol; P450 2E1; P450 3A

Indexed keywords

4 NITROPHENOL; CYTOCHROME P450; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DEXAMETHASONE; PYRAZOLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATALYSIS; ENZYME INDUCTION; KIDNEY; LIVER; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOBIOTIC METABOLISM;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; ENZYME INDUCTION; ENZYME INHIBITORS; KIDNEY; LIVER; MALE; NITROPHENOLS; OXIDOREDUCTASES, N-DEMETHYLATING; PYRAZOLES; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY;

EID: 0031801410     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb04307.x     Document Type: Article

References (42)

1. Guengerich FP, Kim DH, Iwasaki N: Role of human cytochrome P450 2E1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179, 1991
2. Koop DR: Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6:724-729, 1992
3. Wrighton SA, Stevens JC: The human hepatic cytochrome P450 involved in drug metabolism. Crit Rev Toxicol 22:1-21, 1992
4. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochromes P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423, 1994
5. Okey AB: Enzyme induction in the cytochrome P450 system. Pharmacol Ther 45:241-298, 1990
6. Monostory K, Vereczkey L: The effect of phenobarbital and dexamethasone coadministration on the activity of rat liver P450 system. Biochem Biophys Res Commun 203:351-358, 1994
7. Goasduff T, Bellec G, Amet Y, Dréano Y, Ménez JF, Berthou F: P450 2E1 expression in liver, kidney and lung of rats treated with single or combined inducers. Alcohol 13:301-308, 1996
8. Guengerich FP, Mason PS: Immunochemical comparison of hepatic and extrahepatic cytochromes P450. Mol Pharmacol 15:154-164, 1979
9. De Waziers I, Cugnenc C, Yang CS, Le Roux JP, Beaune PH: Cytochrome P450 isoenzymes epoxide and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387-394, 1990
10. Guzelian PS: Regulation of the glucocorticoid-inducible cytochrome P450, in Miners JO, Birkett DJ, McManus M (eds): Microsomes and Drug Oxidations. London, Taylor & Francis, 1988, pp 148-155
11. Koop DR, Crump BL, Nordblom GD, Coon MJ: Immunochemical evidence for induction of the alcohol oxidizing cytochrome P450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc Natl Acad Sci USA 82:4065-4069, 1985
12. Berthou F, Ratanasavanh D, Riché C, Picart D, Voirin T, Guillouzo A: Comparison of caffeine metabolism by slices, microsomes and hepatocyte culture from adult human liver. Xenobiotica 19:401-417, 1989
13. Koop D: Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Mol Pharmacol, 29:399-404, 1986
14. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO: Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975-1981, 1993
15. Peter R, Böcker R, Beaune P, Iwasaki M, Guenguerich FP, Yang CS: Hydroxylation of chlorzoxazone as a specific probe for human cytochrome P450 2E1. Chem Res Toxicol 3:566-573, 1990
16. Lucas D, Ménez JF, Berthou F: Chlorzoxazone in vitro and in vivo substrate probe for liver CYP2E1 cytochrome P450. Methods Enzymol 272:115-123, 1996
17. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolf T, Waxmann DJ: Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation: a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051-5060, 1986
18. Rodrigucs AD: Use of in vitro human metabolism studies in drug development. Biochem Pharmacol 48:2147-2156, 1994
19. Bourrié M, Meunier V, Berger Y, Fabre G: Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277:321-332, 1996
20. Wu D, Cederbaum AI: Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P450 2E1 in rat kidney. J Pharmacol Exp Ther 270:407-413, 1994
21. Porter TD, Khani SC, Coon MJ: Induction and tissue-specific expression of rabbit cytochrome P450 IIE1 and IIE2 genes. Mol Pharamcol 36:61-65, 1989
22. Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, et al.: Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1:542-547, 1987
23. Zerilli A, Lucas D, Amet Y, Beaugé F, Floch HH, Ménez JF: Cytochrome P450 2E1 in rat liver, kidney and lung microsomes after chronic administration of ethanol either orally or by inhalation. Alcohol Alcohol 30:357-365, 1995
24. Roberts BJ, Shoaf SE, Song BJ: Rapid changes in cytochrome P450 2E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats. Biochem Pharmacol 49:1665-1673, 1995
25. Louis CA, Wood SG, Kostrubsky V, Sinclair PR, Sinclair JF: Synergistic increases in rat hepatic cytochrom P450s by ethanol and isopentanol. J Pharamacol Exp Ther 269:838-845, 1994
26. Kostrubsky VE, Strom SC, Wood SG, Wrighton SA, Sinclair PR, Sinclair JF: Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch Biochem Biophys 322:516-520, 1995
27. Paolini M, Mesirca R, Pozetti L, Sapone A, Cantelli-Forti G: Biomarkers of effect in evaluating metalaxyl cocarcinogenesis. Selective induction of murine CYP 3A isoforms. Mut Res 361:157-164, 1996
28. Winters DK, Cederbaum AI: Time course characterization of the induction of cytochrome P450 2E1 by pyrazole and 4-methylpyrazole. Biochim Biophys Acta 1117:15-24, 1992
29. Carrière V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, et al.: Both cytochrome P450 P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857, 1993
30. Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, Gonzalez FJ: Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5:143-150, 1995
31. Gorski JC, Jones DR, Wrighton SA, Hall SD: Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica 27:243-256, 1997
32. Jayyosi Z, Knoble D, Mac M, Erick J, Thomas PE, Kelley M: Cytochrome P450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver. J Pharmacol Exp Ther 273:1156-1161, 1995
33. Gonzalez FJ, Song BJ, Hardwick JP: Pregnenolone 16-α-carbonitrile inducible P450 gene family and differential regulation. Mol Cell Biol 6:2969-2976, 1986
34. Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley, Ryan DE, et al.: Regulation of 2 members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch Biochem Biophys 301:345-354, 1993
35. Mahnke A, Strotkamp R, Roos PH, Hanstein WG, Chabot GG, Nef P: Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biphys 337:62-68, 1997
36. Murayama NK, Miyata M, Shimada M, Yamazoe Y, Kato R: Isolation and characterization of a new rat P450 (CYP3A18) cDNA encoding P450((6)beta-2 catalyzing testosterone 6-beta and 16-alpha-hydroxylations. Pharmacogenetics 6:103-111, 1996
37. Maurel P: The CYP3A family, in Ioannides C (ed): Cytochromes P450: metabolic and toxicological aspects. Boca Raton: CRC Press, 1996, pp 241-270
38. Yamazaki H, Guo Z, Guengerich FP: Selectivity of cytochrome P450 2E1 in chlorzoxazone 6-hydroxylation. Drug Metab Dispos 23:438-440, 1995
39. Carrière V, Berthou F, Baird S, Belloc C, Beaune P, De Waziers I: Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 6:203-211, 1996
40. Girre C, Lucas D, Hispard E, Ménez C, Dally S, Ménez JF: Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508, 1996
41. Lucas D, Menez C, Floch F, Girre C, Bodenez P, Hispard E, et al: Decrease in cytochrome P450 2E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res 19:362-366, 1995
42. Liu C, Zhuo X, Gonzalez FJ, Ding X: Baculovirus-mediated expression and characterization of rat CYP2A3 and CYP2A6: role in metabolic activation of nasal toxicants. Mol Pharmacol 50:781-788, 1996